Published in J Virol on October 01, 1995
Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol (1997) 1.59
The papillomavirus E2 proteins. Virology (2013) 1.30
Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. J Virol (2000) 1.27
Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. J Virol (2002) 1.10
Identification of TAZ as a binding partner of the polyomavirus T antigens. J Virol (2004) 1.05
Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2. J Virol (1997) 0.98
Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1. J Virol (1997) 0.83
A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein. J Virol (2001) 0.83
Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J Mol Appl Genet (1983) 8.94
Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell (1987) 7.75
Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell (1985) 7.56
Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell (1987) 7.51
A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator. Cell (1987) 5.75
Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature (1987) 5.61
Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques (1990) 5.02
PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci U S A (1993) 4.05
Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science (1993) 3.88
The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J (1987) 3.86
Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev (1989) 3.41
Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology (1993) 3.37
Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers. EMBO J (1987) 3.09
Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol (1990) 2.90
Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol (1990) 2.69
Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene (1993) 2.67
The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. EMBO J (1988) 2.66
The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J Virol (1989) 2.50
Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. J Virol (1990) 2.34
PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol Cell Biol (1994) 2.27
The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev (1991) 2.24
Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biol (1991) 2.02
The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol (1994) 2.01
Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies. J Virol (1988) 1.98
Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells. J Virol (1989) 1.97
Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J Virol (1994) 1.90
Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain. EMBO J (1988) 1.79
During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res (1992) 1.69
The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol (1990) 1.68
The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes Dev (1990) 1.66
A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors. Cell Growth Differ (1990) 1.27
A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor. J Virol (1990) 1.25
Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J Virol (1990) 1.17
Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. Carcinogenesis (1994) 1.09
Comparison of methods for transfection of human epidermal keratinocytes. J Invest Dermatol (1991) 1.08
A novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the mammary gland skin: a member of a proposed new BPV subgroup. Virology (1984) 0.98
Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor. J Virol (1994) 0.89
Positive and negative E2-independent regulatory elements in the long control region of bovine papillomavirus type 4. J Gen Virol (1991) 0.85
Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity. Mol Carcinog (1993) 0.84
Analysis of the transforming functions of bovine papillomavirus type 4. Virology (1993) 0.83
An element binding a C/EBP-related transcription factor contributes to negative regulation of the bovine papillomavirus type 4 long control region. J Gen Virol (1994) 0.82
Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts. J Gen Virol (1990) 0.82
Mapping of two novel transcripts of bovine papillomavirus type 4. J Gen Virol (1988) 0.79
Synergism between bovine papillomavirus type 4 and the flavonoid quercetin in cell transformation in vitro. Virology (1992) 0.77
Conservation of cytoplasmic poly (A)-containing RNA in mouse and rat. Nature (1975) 2.18
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology (1996) 2.08
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology (1991) 1.70
Transcriptional control signals in the genome of bovine papillomavirus type 1. Nature (1983) 1.70
Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology (1995) 1.48
Persistence of non-integrated viral DNA in bovine cells transformed in vitro by bovine papillomavirus type 2. Nature (1981) 1.35
Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies. J Gen Virol (1996) 1.32
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Tandem integration of complete and defective SV40 genomes in mouse-human somatic cell hybrids. Cell (1978) 1.24
Two classes of messenger RNA in cultured rat cells: repetitive sequence transcripts and unique sequence transcripts. J Mol Biol (1974) 1.16
Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination. Vet Rec (1990) 1.15
Unintegrated viral DNA sequences in a hamster tumor induced by bovine papilloma virus. J Virol (1981) 1.14
Molecular heterogeneity and lesion site specificity of cutaneous bovine papillomaviruses. Virology (1981) 1.13
Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Vet Rec (1990) 1.11
alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4. J Gen Virol (2000) 1.09
Association of bovine papillomavirus with the equine sarcoid. J Gen Virol (2003) 1.07
The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frame. Mol Carcinog (1991) 1.06
Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16. J Gen Virol (1990) 1.01
DNA-RNA hybridization. Philos Trans R Soc Lond B Biol Sci (1975) 0.99
The nucleotide sequence and genome organization of bovine papillomavirus type 4. J Gen Virol (1987) 0.99
Molecular cloning and characterization of human papillomavirus type 7 DNA. Virology (1986) 0.98
Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Virus Res (2006) 0.98
A novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the mammary gland skin: a member of a proposed new BPV subgroup. Virology (1984) 0.98
Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours. Oncogene (2006) 0.96
The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. J Virol (1996) 0.95
Repetitious and unique sequences in the heterogeneous nuclear and cytoplasmic messenger RNA of mammalian and insect cells. Cell (1974) 0.92
Role of different sponge cell types in species specific cell aggregation. Nat New Biol (1971) 0.91
Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. Virology (2008) 0.89
The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1. J Virol (1995) 0.87
DNA sequences of human papillomavirus types 11, 16, and 18 in lesions of the uterine cervix in the west of Scotland. Br Med J (Clin Res Ed) (1986) 0.87
Molecularly cloned bovine papillomavirus DNA transforms mouse fibroblasts in vitro. J Gen Virol (1983) 0.86
Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol (1991) 0.86
The biology of papillomaviruses and their role in oncogenesis. Anticancer Res (1985) 0.86
Biosynthesis and distribution of ribosomal particles in the cellular slime mould, Dictyostelium purpureum. J Mol Biol (1970) 0.85
Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res (2003) 0.85
E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H(+)-ATPase. J Gen Virol (2001) 0.85
Positive and negative E2-independent regulatory elements in the long control region of bovine papillomavirus type 4. J Gen Virol (1991) 0.85
Phenotypical characterization of lymphocytes infiltrating regressing papillomas. J Virol (1996) 0.85
Molecular cloning of bovine papillomavirus genomes and comparison of their sequence homologies by heteroduplex mapping. J Gen Virol (1982) 0.84
Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity. Mol Carcinog (1993) 0.84
Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland. Br J Dermatol (2009) 0.84
Analysis of the transforming functions of bovine papillomavirus type 4. Virology (1993) 0.83
A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein. J Virol (2001) 0.83
Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1. J Gen Virol (2008) 0.82
Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2. Virus Res (2005) 0.82
Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts. J Gen Virol (1990) 0.82
Extensive papillomatosis of the bovine upper gastrointestinal tract. J Comp Pathol (2003) 0.82
Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection. Cancer Immunol Immunother (2001) 0.82
Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J Virol (2008) 0.81
Bovine papillomavirus type 1 DNA and E5 oncoprotein expression in water buffalo fibropapillomas. Vet Pathol (2009) 0.81
Ribosomal subunits in Dictyostelium discoideum. The effect of an ionic detergent and a nonionic detergent. Biochim Biophys Acta (1969) 0.81
Linear B-cell epitopes in the N-terminus of L2 of bovine papillomavirus type 4. Res Vet Sci (1997) 0.81
An enhanced epithelial response of a papillomavirus promoter to transcriptional activators. J Biol Chem (1999) 0.81
Bovine papillomavirus type 4 in oesophageal papillomas of cattle from the south of Italy. J Comp Pathol (2003) 0.81
Multiple Harvey-ras genes in the bovine genome. Oncogene (1989) 0.80
Cooperation between papillomavirus and chemical cofactors in oncogenesis. Crit Rev Oncog (1993) 0.80
Papillomavirus infection in cattle: viral and chemical cofactors in naturally occurring and experimentally induced tumours. Ciba Found Symp (1986) 0.80
Mapping of two novel transcripts of bovine papillomavirus type 4. J Gen Virol (1988) 0.79
T cell responses to BPV-4 E7 during infection and mapping of T cell epitopes. Virology (1995) 0.79
Amplification of specific DNA sequences in C127 mouse cells transformed by bovine papillomavirus type 4. Oncogene (1989) 0.79
Generation of native bovine mAbs by phage display. Proc Natl Acad Sci U S A (1999) 0.79
Malignant transformation of a papilloma induced by bovine papillomavirus type 4 in the nude mouse renal capsule. J Gen Virol (1991) 0.79
Sequence homologies between bovine papillomavirus genomes mapped by a novel low-stringency heteroduplex method. Virology (1985) 0.78
Transcriptional organization of bovine papillomavirus type 4. J Gen Virol (1986) 0.78
Ribosomal subunit exchange in Dictyostelium purpureum. J Cell Biol (1970) 0.78
Alimentary fibropapilloma in cattle: a spontaneous tumor, nonpermissive for papillomavirus replication. J Natl Cancer Inst (1984) 0.78
Quercetin, E7 and p53 in papillomavirus oncogenic cell transformation. Carcinogenesis (2001) 0.78
Bovine papillomavirus type 1 E2 and E7 proteins down-regulate Toll Like Receptor 4 (TLR4) expression in equine fibroblasts. Virus Res (2010) 0.78
Cell transformation by the E5/E8 protein of bovine papillomavirus type 4. p27(Kip1), Elevated through increased protein synthesis is sequestered by cyclin D1-CDK4 complexes. J Biol Chem (2001) 0.78
Quercetin induces structural chromosomal aberrations and uncommon rearrangements in bovine cells transformed by the E7 protein of bovine papillomavirus type 4. Vet Comp Oncol (2003) 0.78
Novel variants of human papillomavirus type 2 in warts from immunocompromised individuals. Br J Dermatol (1989) 0.78
Downregulation of major histocompatibility complex class I in bovine papillomas. J Gen Virol (2004) 0.78
Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus type 1 isolated from equine sarcoids. Virology (2007) 0.78
BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1. Oncogene (1998) 0.78
Papillomaviruses and their involvement in oncogenesis. Biomed Pharmacother (1985) 0.78
Viral proteins of bovine papillomavirus type 4 during the development of alimentary canal tumours. Vet J (1997) 0.78
The synergism between bovine papillomavirus type 4 and quercetin is dependent on the timing of exposure. Carcinogenesis (1995) 0.77
Epithelial specific transcriptional regulation of the bovine papillomavirus 4 promoter by E2. J Gen Virol (1998) 0.77
Synergism between bovine papillomavirus type 4 and the flavonoid quercetin in cell transformation in vitro. Virology (1992) 0.77
The BPV-4 co-carcinogen quercetin induces cell cycle arrest and up-regulates transcription from the LCR of BPV-4. Oncogene (1998) 0.77
PEF-1, an epithelial cell transcription factor which activates the long control region of human papillomavirus type 16, is glycosylated with N-acetylglucosamine. J Gen Virol (1998) 0.77
The bovine papillomavirus type 4 long control region contains an epithelial specific enhancer. J Gen Virol (1999) 0.77
The genomes of bovine papillomaviruses types 3 and 4 are colinear. J Gen Virol (1983) 0.76
The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus. Oncogene (2006) 0.76
A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4. Virology (1999) 0.76
Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopes. Virology (1994) 0.76
The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I. Virology (2006) 0.75
R-loop mapping of RNA transcripts from bovine papillomavirus type 4. Br J Cancer Suppl (1988) 0.75
Interaction between bovine papillomavirus type 4 and cocarcinogens in the production of malignant tumours. J Gen Virol (1993) 0.75
The role of exogenous p53 and E6 oncoproteins in in vitro transformation by bovine papillomavirus type 4 (BPV-4): significance of the absence of an E6 ORF in the BPV-4 genome. J Gen Virol (1997) 0.75
A new cytoplasmic ribonucleoprotein particle in the cellular slime mold, Dictyostelium purpureum. Biochim Biophys Acta (1970) 0.75
Papillomas of the teats and udder of cattle and their causal viruses. Vet Rec (1984) 0.75
BPV-4 induces amplification and activation of 'silent' BPV-1 in a sub-line of C127 cells. Oncogene (1993) 0.75
HPV-18 transformed cells fail to arrest in G1 in response to quercetin treatment. Virus Res (2005) 0.75
Brief report: antibody response to E6, E7, and L1 proteins of human papillomavirus 16 in an Italian population. J Med Virol (1994) 0.75
Papillomavirus research: a growth area. Microbiol Sci (1984) 0.75
Equine sarcoids are not induced by an infectious cell line. Equine Vet J (2007) 0.75
Assignment of the bovine p53 gene (TP53) to chromosome 19q15 by fluorescence in situ hybridization. Mamm Genome (1995) 0.75